PageOverview.com
 

Domains targeting keyword peripheral blood

Keyword peripheral blood was used in the provided list of websites.

 
Number of websites/domains displayed: 12
Results found: 12
 

Similar searches:

 

Websites discovered:

BYSTOLIC (nebivolol) – Official Site
http://pageoverview.com/website-report/bystolic.com
Learn more about Bystolic and find information for patients, including side effects, treatment, indication, FAQs, and resources. Bystolic is a blood pressure medication that may effectively lower blood pressure when it is persistently elevated. Tell your doctor if your symptoms of heart failure worsen. Bystolic must not be taken if you have a slow heartbeat or your heart skips beats (irregular heartbeat); have severe liver damage; or are allergic to any ingredient in Bystolic. The active ingredient is nebivolol. Do not take Bystolic if you are under the age of 18 as Bystolic is not approved for use in children under 18. The most common side effects people taking Bystolic report are headache, fatigue (tiredness), dizziness (if you feel dizzy, sit or lie down and tell your doctor right away), diarrhea, nausea, insomnia (difficulty falling or staying asleep), chest pain, bradycardia (slow heartbeat), dyspnea (shortness of breath), rash, and peripheral edema (leg swelling due to fluid retention). Other possible side effects include masking (hiding) the symptoms of low blood sugar and hyperthyroidism (overactive thyroid), especially a fast heartbeat. Tell your doctor if you gain weight or have trouble breathing while taking Bystolic. This is not a complete list of side effects. Tell your doctor if you have any side effects that bother you or don’t go away.
  • Expected expiration: September 27th in 2021
  • Creation date: September 27th in 2007
  • Renew date: March 23rd in 2017
London Heart Centre | Private Cardiology Services | Cardiology Clinic
http://pageoverview.com/website-report/londonheartcentre.co.uk
London Heart Centre was founded by a group of London cardiologists as a cardiac diagnostic centre providing range of services like ECG, Exercise test, Heart rate monitoring, 24 hour blood pressure monitoring, Cardiac event monitoring.
  • Renew date: February 10th in 2018
  • Google Analytics: 33543754-1
Neurology Advisor
http://pageoverview.com/website-report/neurologyadvisor.com
Find the latest neurology news, meeting coverage and clinical guidance plus expert opinion from clinicians who treat diseases and disorders of the brain; the central and peripheral nervous systems; and the blood vessels that support them.
  • Expected expiration: February 6th in 2018
  • Creation date: February 6th in 2014
  • Renew date: February 2nd in 2016
  • Google Plus Account: 116570570845706837724
Stroke Detection Plus | Mobile Vascular Screening
http://pageoverview.com/website-report/strokedetectionplus.com
Stroke Detection Plus is a mobile vascular screening company. We make stroke and cardiovascular disease screenings convenient, affordable and accurate, to identify at-risk patients and help save lives.
  • Expected expiration: January 25th in 2021
  • Creation date: January 25th in 2005
  • Renew date: January 12th in 2017
  • Google Analytics: 13053368-1
Veinplicity: Revolutionizing venous access
http://pageoverview.com/website-report/veinplicity.com
Electrical stimulation device, Veinplicity, increases blood flow in the forearm and stabilizes peripheral veins for easier venous access.
  • Expected expiration: June 9th in 2018
  • Creation date: June 9th in 2015
  • Renew date: June 2nd in 2017
  • Google Analytics: 85357675-1
Pacific Vascular Inc., Specialists in Vascular Diagnostic Ultrasound
http://pageoverview.com/website-report/pacificvascular.com
Pacific Vascular has multiple vascular laboratories in WA. For scheduling, call 425-486-8868 or 800-282-6516 toll free. Same day appointments available!
  • Expected expiration: November 28th in 2020
  • Creation date: November 29th in 1996
  • Renew date: September 29th in 2017
  • Google Plus Account: 110010809539723156889
Perimed-Peripheral vascular diagnosis made intelligent
http://pageoverview.com/website-report/perimed-instruments.com
Perimed AB provides instrument solutions for accurate diagnosis of the peripheral vascular circulation. In addition, advanced blood perfusion imagers based on laser speckle and laser Doppler technique, for high-level research within the microcirculation area.
  • Expected expiration: October 20th in 2017
  • Creation date: October 20th in 2009
  • Renew date: January 17th in 2017
  • AddThis User: ra-560bd476b433059d
Patients and Caregivers
http://pageoverview.com/website-report/leukine.com
Leukine® (sargramostim) is contraindicated in patients with excessive leukemic myeloid blasts in bone marrow or peripheral blood (≥ 10%), in patients with known hypersensitivity to GM-CSF, yeast derived products or any components of Leukine, and for concomitant use with chemotherapy and radiotherapy. Please see Full Prescribing Information.
  • Expected expiration: September 29th in 2018
  • Creation date: September 30th in 1998
  • Renew date: September 25th in 2016
  • Google Analytics: 7433141-25
Inducing Remission in GPA & MPA Patients | Rituxan® GPA & MPA | HCP
http://pageoverview.com/website-report/rituxanforgpampa-hcp.com
Find information for healthcare professionals about Rituxan® (rituximab), the only FDA-approved treatment proven to induce remission in patients with GPA and MPA. INDICATION STATEMENT - Rituxan® (rituximab), in combination with glucocorticoids, is indicated for the treatment of adult patients with Granulomatosis with Polyangiitis (GPA) (Wegener’s Granulomatosis) and Microscopic Polyangiitis (MPA) - Limitations of Use: Rituxan is not recommended for use in patients with severe, active infections BOXED WARNINGS and Additional Important Safety Information BOXED WARNINGS Infusion Reactions: Rituxan administration can result in serious, including fatal, infusion reactions. Deaths within 24 hours of Rituxan infusion have occurred. Approximately 80% of fatal infusion reactions occurred in association with the first infusion. Monitor patients closely. Discontinue Rituxan infusion for severe reactions and provide medical treatment for Grade 3 or 4 infusion reactions. Severe Mucocutaneous Reactions: Severe, including fatal, mucocutaneous reactions can occur in patients receiving Rituxan. Hepatitis B Virus (HBV) Reactivation: HBV reactivation can occur in patients treated with Rituxan, in some cases resulting in fulminant hepatitis, hepatic failure, and death. Screen all patients for HBV infection before treatment initiation, and monitor patients during and after treatment with Rituxan. Discontinue Rituxan and concomitant medications in the event of HBV reactivation. Progressive Multifocal Leukoencephalopathy (PML): PML, including fatal PML, can occur in patients receiving Rituxan. Warnings and Precautions Rituxan administration can also result in additional serious, including fatal, adverse reactions including: - Tumor lysis syndrome (TLS): Administer aggressive intravenous hydration, anti‑hyperuricemic agents, monitor renal function - Infections: Withhold Rituxan and institute appropriate anti-infective therapy - Cardiac arrhythmias and angina: Discontinue infusions in case of serious or life-threatening events - Bowel obstruction and perforation: Consider and evaluate for abdominal pain, vomiting, or related symptoms - Live virus vaccines: Do not administer live virus vaccines prior to or during Rituxan - Cytopenias: Monitor blood counts at regular intervals Granulomatosis With Polyangiitis (GPA) (Wegener’s Granulomatosis) and Microscopic Polyangiitis (MPA) - Use of concomitant immunosuppressants other than corticosteroids has not been studied in GPA or MPA patients exhibiting peripheral B-cell depletion following treatment with Rituxan. Observe patients with GPA and MPA closely for signs of infection if immunosuppressants other than corticosteroids are used concomitantly - The safety and efficacy of retreatment with Rituxan have not been established in patients with GPA and MPA - Common adverse reactions (≥15%) in the clinical study were infections, nausea, diarrhea, headache, muscle spasms, anemia, and peripheral edema. Other important adverse reactions include infusion reactions You may report side effects to the FDA at (800) FDA-1088 or www.fda.gov/medwatch. You may also report side effects to Genentech at (888) 835-2555. For additional safety information, please see the Rituxan full prescribing information, including BOXED WARNINGS.
  • Expected expiration: November 27th in 2019
  • Creation date: November 27th in 2013
  • Renew date: December 1st in 2017
  • Google Analytics: 48974804-1
XtendOvite
http://pageoverview.com/website-report/heartdrop.com
Heart Drop 2000, XtendOvite Helps Maintain Cardiovascular Health and Reduce Blood Lipid levels In Adults.
  • Expected expiration: March 17th in 2021
  • Creation date: March 17th in 2000
  • Renew date: January 16th in 2018
  • Google Analytics: 20566459-1
Heart360 - Welcome
http://pageoverview.com/website-report/heart360.org
  • Expected expiration: April 10th in 2018
  • Creation date: April 10th in 2008
  • Renew date: March 1st in 2017
  • Google Analytics: 12551341-17
Mesuron LLC   Magnetocardiography MCG SQUIDs
http://pageoverview.com/website-report/mesuron.com
Magnetocardiography MCG Mesuron LLC is a US commercial company specializing in the development and fabrication of SQUID-based magnetometers ( SQUID Magnetometer ) for various applications including Clinical MagnetoCardioGraphy ( MCG ) systems for heart scan procedures.
  • Expected expiration: February 5th in 2019
  • Creation date: February 5th in 2008
  • Renew date: February 6th in 2016
  • Adsense ID: pub-5064955246030968
  • Google Analytics: 44258597-2
  • Google Plus Account: 109840131710563325662
0.0118 // 2024-05-27 12:52:47
All Rights reserved 2018 © PageOverview.com